Miaoli, Taiwan

Yi-Yu Ke

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: National Health Research Institutes. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi-Yu Ke. Retrieved from https://idiyas.com/inventor/yi-yu-ke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yi-Yu Ke in Pharmaceutical Chemistry

Introduction

Yi-Yu Ke is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrimidine compounds. His research focuses on the development of new compounds that have potential applications in treating various diseases, including cancer.

Latest Patents

Yi-Yu Ke holds a patent for "Pyrimidine compounds and their pharmaceutical uses." This patent details pyrimidine compounds of Formula (I), with specific assignments to the variables in the formula outlined in the documentation. The patent also discloses a method of treating cancer using one of the pyrimidine compounds, showcasing the potential therapeutic applications of his inventions. He has 1 patent to his name.

Career Highlights

Yi-Yu Ke is affiliated with the National Health Research Institutes, where he conducts his research and development activities. His work at this esteemed institution has allowed him to focus on innovative solutions in the pharmaceutical field, contributing to advancements in cancer treatment.

Conclusion

Yi-Yu Ke's contributions to pharmaceutical chemistry, particularly through his patent on pyrimidine compounds, highlight his role as an inventor dedicated to improving healthcare solutions. His work exemplifies the impact of innovation in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…